SlideShare a Scribd company logo
1 of 8
What percentage of newly 
diagnosed Colorectal Cancer are 
stage 4? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed Colorectal Cancer are 
stage 1? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
What percentage of newly 
diagnosed Colorectal Cancer are 
stage 3? 
A.<10% 
B.10-30% 
C.30-50% 
D.50-80% 
E.Greater than 80%
Do you routinely prescribe 
Neoadjuvant Chemotherapy for 
Resectable Pancreatic Cancer?? 
A.Yes 
B.No
How many newly diagnosed 
Cholangiocarcinoma do you see 
per year? 
A.<10 
B.10-30 
C. Greater than 30
Do you routinely prescribe 
Cetuximab to Paclitaxel+ 
Cisplatin+ Radiation for 
Esophageal Cancer treated 
WITHOUT Surgery? 
A. Yes 
B.NO
How many newly diagnosed Liver 
Cancers do you see per year? 
A.<10 
B.10-30 
C. Greater than 30
First Treatment of choice for 
newly diagnosed Stage 4 Liver 
Cancer? 
A.Sorafenib (Nexavar) therapy 
B.Bevacizumab (Avastin) 
C.Chemotherapy 
D.Palliative Care

More Related Content

Similar to Ars gastrointestinal cancer update ก่อน 1530

Advanced&metastatic breast cancer
Advanced&metastatic breast cancerAdvanced&metastatic breast cancer
Advanced&metastatic breast cancerMahran Alnahmi
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
Ovarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisOvarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisSibley Memorial Hospital
 
Hep b and c powerpoint final
Hep b and c powerpoint finalHep b and c powerpoint final
Hep b and c powerpoint finalacatanzaro
 
Role of Radiation Therapy in gastric cancer
Role of Radiation Therapy  in gastric cancerRole of Radiation Therapy  in gastric cancer
Role of Radiation Therapy in gastric cancerDr Manas Dubey
 
Adjuvant radiotherapy for endmetrium
Adjuvant radiotherapy for endmetriumAdjuvant radiotherapy for endmetrium
Adjuvant radiotherapy for endmetriumAjay Sasidharan
 
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®
Epatocarcinoma: nulla di nuovo sotto il sole -  Gastrolearning®Epatocarcinoma: nulla di nuovo sotto il sole -  Gastrolearning®
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®Gastrolearning
 
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®Gastrolearning
 
Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...David Halsall
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...European School of Oncology
 
esophaguscancer
esophaguscanceresophaguscancer
esophaguscancerAbiVill
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptxDeveshAhir
 

Similar to Ars gastrointestinal cancer update ก่อน 1530 (20)

Advanced&metastatic breast cancer
Advanced&metastatic breast cancerAdvanced&metastatic breast cancer
Advanced&metastatic breast cancer
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
 
Esophagus cancer
Esophagus cancerEsophagus cancer
Esophagus cancer
 
Ovarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after DiagnosisOvarian Cancer: Treatment Options after Diagnosis
Ovarian Cancer: Treatment Options after Diagnosis
 
Hep b and c powerpoint final
Hep b and c powerpoint finalHep b and c powerpoint final
Hep b and c powerpoint final
 
Ca stomach
Ca stomachCa stomach
Ca stomach
 
Role of Radiation Therapy in gastric cancer
Role of Radiation Therapy  in gastric cancerRole of Radiation Therapy  in gastric cancer
Role of Radiation Therapy in gastric cancer
 
Adjuvant radiotherapy for endmetrium
Adjuvant radiotherapy for endmetriumAdjuvant radiotherapy for endmetrium
Adjuvant radiotherapy for endmetrium
 
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®
Epatocarcinoma: nulla di nuovo sotto il sole -  Gastrolearning®Epatocarcinoma: nulla di nuovo sotto il sole -  Gastrolearning®
Epatocarcinoma: nulla di nuovo sotto il sole - Gastrolearning®
 
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
Dalle linee guida dell'epatocarcinoma alla pratica clinica - Gastrolearning®
 
Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...Modelling your way out of the poo: predicting the impact of early diagnosis o...
Modelling your way out of the poo: predicting the impact of early diagnosis o...
 
Ovarian Carcinoma
Ovarian CarcinomaOvarian Carcinoma
Ovarian Carcinoma
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Treatment of...
 
esophaguscancer
esophaguscanceresophaguscancer
esophaguscancer
 
Cancer ovarian .pptx
Cancer ovarian .pptxCancer ovarian .pptx
Cancer ovarian .pptx
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptx
 
GI and Liver Malignancies
GI and Liver MalignanciesGI and Liver Malignancies
GI and Liver Malignancies
 
Cancer screening
Cancer screeningCancer screening
Cancer screening
 

More from spa718

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotaispa718
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery spa718
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancerspa718
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancerspa718
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerspa718
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinomaspa718
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancerspa718
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancerspa718
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancerspa718
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancerspa718
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancerspa718
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancerspa718
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancerspa718
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015spa718
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancerspa718
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHDspa718
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myelomaspa718
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapyspa718
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapyspa718
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Updatespa718
 

More from spa718 (20)

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancer
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancer
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancer
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancer
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancer
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancer
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancer
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancer
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancer
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myeloma
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapy
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapy
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Update
 

Ars gastrointestinal cancer update ก่อน 1530

  • 1. What percentage of newly diagnosed Colorectal Cancer are stage 4? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 2. What percentage of newly diagnosed Colorectal Cancer are stage 1? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 3. What percentage of newly diagnosed Colorectal Cancer are stage 3? A.<10% B.10-30% C.30-50% D.50-80% E.Greater than 80%
  • 4. Do you routinely prescribe Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?? A.Yes B.No
  • 5. How many newly diagnosed Cholangiocarcinoma do you see per year? A.<10 B.10-30 C. Greater than 30
  • 6. Do you routinely prescribe Cetuximab to Paclitaxel+ Cisplatin+ Radiation for Esophageal Cancer treated WITHOUT Surgery? A. Yes B.NO
  • 7. How many newly diagnosed Liver Cancers do you see per year? A.<10 B.10-30 C. Greater than 30
  • 8. First Treatment of choice for newly diagnosed Stage 4 Liver Cancer? A.Sorafenib (Nexavar) therapy B.Bevacizumab (Avastin) C.Chemotherapy D.Palliative Care